- In March 2025, GE HealthCare announced the U.S. launch of its MAC IQ ECG system at the American College of Cardiology (ACC) 2025 conference. The system features advanced AI-driven analysis tools for early detection of subtle cardiac abnormalities and integrates cloud connectivity for seamless data sharing. This underscores the company's dedication to delivering innovative, reliable diagnostic solutions tailored to the evolving needs of the healthcare market.
- In February 2025, Philips advanced its remote cardiac monitoring solutions through its BioTel Heart division, enhancing Mobile Cardiac Telemetry (MCOT) devices with improved algorithms for arrhythmia detection and treatment. This advancement highlights Philips' commitment to developing cutting-edge technologies that safeguard vulnerable spaces and offer greater protection and peace of mind for patients and healthcare providers.
- In November 2024, Hill-Rom's Welch Allyn CP 300 ECG system was updated with a new user interface and better data management capabilities. It also offers EMR connectivity and an intuitive touchscreen for primary care clinics and emergency departments. This project highlights the increasing significance of smart technology in urban safety, contributing to the development of safer, smarter communities.
- In October 2024, BPL Medical Technologies launched the Cardiart GenX3, a 3-channel ECG machine featuring the Glasgow ECG Interpretation algorithm. It's designed for use in clinics and hospitals, offering real-time data transfer capabilities. This collaboration is designed to enhance diagnostic efficiency and streamline accessibility for healthcare professionals, facilitating more efficient and accurate cardiac assessments.
- In January 2021, BioTelemetry, Inc., a prominent provider of remote cardiac diagnosis and monitoring systems in the United States, was acquired by Koninklijke Philips N.V. This strategic acquisition enhances Philips' portfolio of patient care management solutions, offering healthcare providers enhanced convenience and control while ensuring robust diagnostic capabilities.
